Company:
About
- President and Chief Executive Officer of Eliem Therapeutics Inc., a biotechnology company focused on neuronal excitability disorders, from 2020 until 2023
- President and Chief Executive Officer of Alder BioPharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on prevention of chronic migraines, from 2018 until company was acquired by Lundbeck in 2019
- Executive Vice President and Chief Commercial Officer of Juno Therapeutics Inc., a biopharmaceutical company, from 2015 until the company was acquired by Celgene in 2018
- Held various senior roles at Amgen, a multinational biopharmaceutical company, from 2000 until 2015
- Other current public company directorships:
- ADC Therapeutics SA, a commercial-stage biotechnology company since 2023
- Autolus Therapeutics plc, a CAR T cell therapy company, since January 2024
- Prior public company directorships within the last five years:
- Chinook Therapeutics Inc., a clinical-stage biopharmaceutical company, from 2023 until the company was acquired later in 2023
- Eliem Therapeutics Inc., a biotechnology company, from 2020 until 2023
- Clovis Oncology Inc., a pharmaceutical company, from 2018 until 2022
- Immunomedics, a biotechnology company, from 2020 until the company was acquired later in 2020
- Alder BioPharmaceuticals Inc., a clinical-stage biopharmaceutical company, from 2018 until the company was acquired in 2019
Personal Details
Title: Mr
Surname: Azelby
DoB: 01/01/2025
Age: 1 years
M/F: Male
Nationality: American
Country of Birth: United States of America
Language: English
Qualification: BA, Economics and Religious Studies, MBA
Industry:
Qualifications & Experience
Industry Experience +5yrs:
Industry Qualification +5yrs?:
Finance experience +5yrs?:
Finance Qualification +5yrs:
Legal experience +5yrs?:
Delinquent director?:
Other Experiences?:
Collapsed company director?:
Other directorships (state)
(only entities turnover at least $5m p/a)
| Company | Committee | Position | Date Appointed |
|---|---|---|---|
| Board | Other Non-Executive | 01/06/2023 | |
| Board | Other Non-Executive | 01/01/2024 |
Working history
Committee/s
| Company | Committee | Role | Appointment Date | Resignation Date |
|---|---|---|---|---|
| Cardinal Health | Board | Member | 01/03/2024 | |
| Cardinal Health | Risk & Compliance | Member | 01/03/2024 |
Independence Questions
Any family members working for the company?:
Are you doing business with the company?:
Do you hold shares in the company for more than 0.10%? (directly or by representation):
Is your Director annual fee more than 5% of your total income from all sources?:
Are you more than 10 years as a director?:
Are you an executive chairperson?:
InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.